Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice

Encephalitis in adults caused by herpes simplex virus

Ronak K. Kapadia, Kenneth L. Tyler and Daniel M. Pastula
CMAJ August 10, 2020 192 (32) E919; DOI: https://doi.org/10.1503/cmaj.191636
Ronak K. Kapadia
Neuro-Infectious Diseases Group, Department of Neurology and Division of Infectious Diseases (Kapadia, Tyler, Pastula), University of Colorado School of Medicine, Aurora, Colo.; Division of Neurology (Kapadia), Department of Clinical Neurosciences, University of Calgary, Cummings School of Medicine, Calgary, Alta.; Department of Epidemiology (Pastula), Colorado School of Public Health, Aurora, Colo.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth L. Tyler
Neuro-Infectious Diseases Group, Department of Neurology and Division of Infectious Diseases (Kapadia, Tyler, Pastula), University of Colorado School of Medicine, Aurora, Colo.; Division of Neurology (Kapadia), Department of Clinical Neurosciences, University of Calgary, Cummings School of Medicine, Calgary, Alta.; Department of Epidemiology (Pastula), Colorado School of Public Health, Aurora, Colo.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel M. Pastula
Neuro-Infectious Diseases Group, Department of Neurology and Division of Infectious Diseases (Kapadia, Tyler, Pastula), University of Colorado School of Medicine, Aurora, Colo.; Division of Neurology (Kapadia), Department of Clinical Neurosciences, University of Calgary, Cummings School of Medicine, Calgary, Alta.; Department of Epidemiology (Pastula), Colorado School of Public Health, Aurora, Colo.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Herpes simplex virus (HSV) is the most commonly identified cause of sporadic acute encephalitis

Herpes simplex virus causes the only viral encephalitis with an effective antiviral treatment; early treatment improves outcomes. Most cases in adults are caused by HSV-1 and occur equally in both sexes. Age of more than 50 years is an important risk factor.1

Early consideration of the diagnosis is important given the broad manifestations of this disease

The diagnosis should be considered in any patient who presents with an acute altered mental status for more than 24 hours or new seizures, typically with fever. Accompanying headache or focal neurologic signs are also common.1

Patients with suspected encephalitis caused by HSV should be started immediately on acyclovir administered intravenously

After starting treatment, investigations for HSV encephalitis and alternative diagnoses can be performed (e.g., lumbar puncture, magnetic resonance imaging [MRI] of the brain with gadolinium and an electroencephalogram [EEG]). A positive result for a cerebrospinal fluid polymerase chain reaction (PCR) test for HSV confirms the diagnosis.2

Cerebrospinal fluid PCR testing may provide a false-negative result within 72 hours of symptom onset

Although the sensitivity and specificity of cerebrospinal fluid PCR testing for HSV is greater than 95% in HSV encephalitis, false-negative results can occur within the first 72 hours of onset. If clinical suspicion is high for HSV encephalitis, continuing treatment and repeating the PCR test for HSV in cerebrospinal fluid between days 3 and 7 after symptom onset is suggested. Other supportive findings include a cerebrospinal fluid pleocytosis, abnormalities on EEG, and brain lesions or enhancement involving the temporal lobe, or orbitofrontal and/or insular cortex on MRI (Appendix 1, available at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.191636/-/DC1).3

Long-term neurologic sequelae are common

Although acyclovir administered intravenously has substantially improved outcomes for HSV encephalitis, (mortality has been reduced from 70% untreated to 8% treated), 35% of those who survive still have long-term neuropsychiatric disabilities including cognitive and seizure disorders.3,4 About 25% of patients with HSV encephalitis also develop autoimmune encephalitis (predominantly anti-NMDA [N-methyl-d-aspartate] receptor encephalitis) within 3 months after recovery from acute symptoms.5

CMAJ invites submissions to “Five things to know about …” Submit manuscripts online at http://mc.manuscriptcentral.com/cmaj

Footnotes

  • Competing interests: None declared.

  • This article has been peer reviewed.

References

  1. ↵
    1. Bradshaw MJ,
    2. Venkatesan A
    . Herpes simplex virus-1 encephalitis in adults: pathophysiology, diagnosis, and management. Neurotherapeutics 2016;13:493–508.
    OpenUrlCrossRef
  2. ↵
    1. Tunkel AR,
    2. Glaser CA,
    3. Bloch KC,
    4. et al
    . The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008;47:303–27.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Stahl JP,
    2. Mailles A
    . Herpes simplex virus encephalitis update. Curr Opin Infect Dis 2019;32:239–43.
    OpenUrlCrossRef
  4. ↵
    1. Raschilas F,
    2. Wolff M,
    3. Delatour F,
    4. et al
    . Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. Clin Infect Dis 2002; 35:254–60.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Armangue T,
    2. Spatola M,
    3. Vlagea A,
    4. et al
    . Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol 2018;17:760–72.
    OpenUrlCrossRef
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 192 (32)
CMAJ
Vol. 192, Issue 32
10 Aug 2020
  • Table of Contents
  • Index by author

Article tools

Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Encephalitis in adults caused by herpes simplex virus
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Encephalitis in adults caused by herpes simplex virus
Ronak K. Kapadia, Kenneth L. Tyler, Daniel M. Pastula
CMAJ Aug 2020, 192 (32) E919; DOI: 10.1503/cmaj.191636

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Encephalitis in adults caused by herpes simplex virus
Ronak K. Kapadia, Kenneth L. Tyler, Daniel M. Pastula
CMAJ Aug 2020, 192 (32) E919; DOI: 10.1503/cmaj.191636
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Herpes simplex virus (HSV) is the most commonly identified cause of sporadic acute encephalitis
    • Early consideration of the diagnosis is important given the broad manifestations of this disease
    • Patients with suspected encephalitis caused by HSV should be started immediately on acyclovir administered intravenously
    • Cerebrospinal fluid PCR testing may provide a false-negative result within 72 hours of symptom onset
    • Long-term neurologic sequelae are common
    • Footnotes
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Infected atrial myxoma presenting with purpura
  • Mild bleeding disorders in adults
  • Cerebral venous and sinus thrombosis with complicating thromboangiitis obliterans
Show more Practice

Similar Articles

Collections

  • Sections
    • Five Things to Know About
  • Topics
    • Internal medicine
    • Neurology
    • Public health
    • Infectious diseases
    • Imaging
    • Emergency medicine

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of the resources on this site in an accessible format, please contact us at cmajgroup@cmaj.ca.

Powered by HighWire